Exercising can protect the brain from Alzheimer's disease

The researchers also confirmed that regular physical activity may improve the performance of daily activities for people afflicted with Alzheimer's. Their conclusions may have significant implications for the 1.1 million Canadians affected directly or indirectly by dementia.
"As there is no current cure for Alzheimer's, there is an urgent need for interventions to reduce the risk of developing it and to help manage the symptoms," says study first author Kathleen Martin Ginis, professor in UBC Okanagan's School of Health and Exercise Sciences. "After evaluating all the research available, our panel agrees that physical activity is a practical, economical and accessible intervention for both the prevention and management of Alzheimer's disease and other dementias."
Martin Ginis and her cohort reviewed data from more than 150 research articles about the impact of physical activity on people with Alzheimer's. Some of the work explored how physical activity improves the patient's quality of life and the others examined the risk of developing Alzheimer's based on the amount of activity in which an individual participated.
The panel concluded that regular physical activity improves activities of daily living and mobility in in older adults with Alzheimer's and may improve general cognition and balance. They also established that older adults not diagnosed with Alzheimer's who are physically active, were significantly less likely to develop the disease compared to people who were inactive.
"This is exciting work," says Martin Ginis. "From here we were able to prepare a consensus statement and messaging which not only has community backing, but is also evidence-based. Now we have the tool to promote the protective benefit of physical activity to older adults. I'm hopeful this will move the needle on this major health concern."
Alzheimer's disease is the most common form of dementia, characterized by progressive neurodegeneration that results in severe cognitive impairment, compromised physical ability and loss of independence. The number of worldwide cases is expected to increase from 30.8 million in 2010 to more than 106 million in 2050.
for more information visit our product website;     Buy Careprost Eye Drops (With Brush) Online
Location: United States

Comments

Post a Comment

Popular posts from this blog

What is survival among patients with Parkinson, Dementia with lewy bodies?

The population-based study by Rodolfo Savica, M.D., Ph.D., and coauthors of the Mayo Clinic, Rochester Minn., included all the residents of Minnesota's Olmsted County and identified 461 patients with synucleinopathies and 452 patients without for comparison. From 1991 through 2010, the 461 patients with a synucleinopathy diagnosis included 309 with Parkinson disease, 81 with dementia with Lewy bodies, 55 with Parkinson disease dementia and 16 with multiple system atrophy with parkinsonism. Parkinsonism was defined as the presence of at least 2 of 4 cardinal signs: rest tremor, bradykinesia, rigidity and impaired postural reflexes. Of the 461 patients with synucleinopathies, 316 (68.6 percent) died during follow-up, while among the 452 participants used for comparison, 220 (48.7 percent) died during follow-up. Overall, patients with synucleinopathies died about two years earlier than participants without in the comparison group. The highest risk of death was seen among patie...
Read more

Prediction of conversion to Alzheimer's disease with longitudinal measures and time-to-event data

"The growing public health threat posed by Alzheimer's disease has raised urgency to discover and assess prognostic markers for the early detection of the disease," says Sheng Luo, PhD, senior author of the report. "We assessed the comparative predictive utility of thirty-three longitudinal markers in determining the risk of AD conversion at future time points among individuals with MCI. We found that longitudinal measurements of common cognitive and functional tools can provide more accurate prediction regarding AD conversion than volumetric MRI markers for MCI patients, and markers would show different predictive values at different times in disease progression." The data used for this study was from the Alzheimer's Disease Neuroimaging Initiative (ADNI) study. It was very well suited for the tasks because of its large samples, long follow-up period, breadth of cognitive markers and biomarkers, and prospective nature. "We simultaneously modeled t...
Read more

Dementia-related brain changes observed before memory or thinking problems are noticeable

The joint study, published in the  Neurobiology of Aging  on May 8, looked at older adults who are living in the Toronto community without assistance and who were unaware of any major memory problems, but scored below the normal benchmark on a dementia screening test. Within these older adults, researchers also found evidence of less brain tissue in the same subregion of the brain where Alzheimer's disease originates (the anterolateral entorhinal cortex located in the brain's temporal lobe). This U of T-Baycrest study is the first to measure this particular brain subregion in older adults who do not have a dementia diagnosis or memory problems that affect their day-to-day routine. It is also the first study to demonstrate that performance on the Montreal Cognitive Assessment (MoCA) dementia screening test is linked to the volume (size) of this subregion, along with other brain regions affected early in the course of Alzheimer's disease. "This work is an importa...
Read more